6606 — New Horizon Health Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual income statement for New Horizon Health, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 18.8 | 58.3 | 70.6 | 213 | 765 |
| Cost of Revenue | |||||
| Gross Profit | 3.84 | 34.3 | 37.2 | 155 | 646 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 243 | 163 | 851 | 3,290 | 837 |
| Operating Profit | -224 | -105 | -781 | -3,078 | -72.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -225 | -106 | -788 | -3,085 | -79.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -225 | -106 | -789 | -3,085 | -80.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -225 | -106 | -789 | -3,085 | -80.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -225 | -106 | -789 | -3,085 | -80.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.538 | -0.254 | -1.85 | -8.1 | -0.19 |
| Dividends per Share |